by Stemedix | Dec 13, 2021 | Multiple Sclerosis
Multiple sclerosis (MS) is a neurodegenerative disease affecting the spinal cord and brain. MS causes the immune system to attack the myelin–the protective cover that shields nerve fibers. This attack can prevent your brain from communicating effectively with the rest of your body. In time, MS can permanently damage the nerves, resulting in disability. There is currently no cure for MS, but treatments are available to help manage the disease and decrease symptoms. Here we talk about the early warning signs of MS.
Diagnosing Multiple Sclerosis: CIS
MS can be a difficult condition to diagnose early. One reason is that the symptoms present differently from person to person. The first episode most people experience is referred to as a clinically isolated syndrome (CIS).
A CIS typically lasts only 24 hours and occurs when the immune system tells the body to attack myelin. The process is also referred to as demyelination. CIS may cause scarring or leave lesions that make it even more difficult for the brain and body to communicate.
The most common symptoms of CIS include optic neuritis (blurry vision, a dulling of colors, and eye pain) and numbness or tingling in the legs. Those affected may experience only one symptom, known as a monofocal episode, or multiple symptoms, known as a multifocal episode.
CIS is a precursor to MS, but not everyone who experiences a CIS will contract multiple sclerosis. However, if you suspect you’ve had a CIS, it is important to review this information with your specialist.
Primary MS Symptoms
Once the myelin is damaged, a host of other symptoms may occur. Early in the disease, symptoms may be mild and controlled through medication and other therapies.
Early symptoms include the following:
- Bladder and bowel problems (frequent urination, constipation)
- Loss of coordination
- Dizziness
- Emotional changes, fear, and anxiety
- Depression
- Eye problems
- Fatigue
- Muscle spasms
- Sexual dysfunction (Loss of libido, vaginal dryness, erectile problems)
- Overheating
- Cognitive problems
- Difficulty speaking
- Gait and balance problems (trouble walking)
Primary symptoms can lead to secondary and tertiary symptoms, such as getting a bladder infection because you can’t empty your bladder completely or injure yourself from losing balance.
When to Seek Help – If you suspect you’ve experienced a CIS and are exhibiting early warning signs of MS, seek expert medical advice as soon as possible. Both traditional and cutting-edge therapies are most effective when started early. Regenerative medicine, also referred to as stem cell therapy, may have potential as an alternative therapy that improves symptoms without heavy medication.
by Stemedix | Dec 6, 2021 | Health Awareness, Multiple Sclerosis
MS, or multiple sclerosis, is a chronic condition characterized by the immune system attacking the body’s myelin. Myelin is the substance that coats the body’s nerves, so patients with MS often face issues with their nervous system’s ability to communicate. Patients may experience pain, movement issues, or trouble thinking clearly. There are plenty of medical treatment options available, but these options can be costly, inconvenient, or cause troubling side effects. Patients who are wondering what natural treatments are available for Multiple Sclerosis, may have difficulty finding viable information. With this in mind, here are two adaptable natural treatment methods that may show some positive results when incorporated into a comprehensive treatment plan for MS.
Diet
The evidence to support dietary changes is shaky at best. There is no evidence to show that one specific or specialized diet can treat MS symptoms. With that being said, however, there is plenty of scientific data showing that in theory, MS patients adhering to a generally healthy diet may face fewer symptoms.
MS patients can potentially experience some relief by adding these kinds of foods to their diets:
- Omega-3 fatty acids, which are found in fish like salmon and mackerel, as well as some nuts and seeds
- Fruits
- Vegetables
- Whole grains
Patients are advised to cut down on or eliminate high-fat dairy, salt, and saturated fats wherever they can.
Dietary Supplements
Dietary supplements are distinct from herbal supplements, as dietary supplements are meant to replace or bolster naturally-occurring vitamins and minerals needed for regular body function.
Though dietary supplements should not be seen as a cure or treatment for MS, certain vitamin deficits can increase the severity of MS symptoms and flare-ups.
Here are a few dietary supplements that may help to mitigate MS symptoms:
While calcium is not directly related to MS symptoms, it can reduce the risks of osteoporosis, which some MS patients are at a high risk of developing.
Are Natural Treatments Enough?
MS is a complex condition that may require more conventional treatment intervention if the condition is progressing or to help manage symptoms. The options presented here are the easiest and most accessible for MS patients to undertake on their own.
Many patients are also discovering an alternative option through stem cell therapy to additionally help manage the condition. Stem cells have regenerative and anti-inflammatory properties to help damaged tissues and boost the body’s natural healing mechanism.
If you or your loved ones are interested in adopting natural treatments into your MS treatment plan, it is helpful to research and consult if these are viable options to consider. If you are interested in learning more about what natural treatments are available for Multiple Sclerosis, contact a care coordinator today!
by Stemedix | Nov 1, 2021 | Stem Cell Therapy, Multiple Sclerosis, Stem Cell Research
In a recent study, researchers discovered a breakthrough against MS, stem cell therapy might be able to help individuals who have multiple sclerosis (MS). The study was conducted by Italian researchers and included a group of 210 MS patients suffering from aggressive cases of the neurodegenerative condition.
The study spanned over two decades, during which time participants received multiple stem cell transplants. Roughly 140 participants did not experience further degeneration ten years after starting stem cell therapy. The majority of the patients involved in the study were diagnosed with relapsing-remitting MS, the most common type.
Are These Study Results Conclusive?
While the results from this groundbreaking study are promising, they cannot be considered “conclusive.” For instance, many researchers are still unsure which MS patients are most likely to benefit from stem cell therapy. More research is necessary to determine stem cell therapy’s overall effectiveness and identify other relevant factors.
In addition, this study is not considered a clinical trial. This is because stem cell therapy was not tested against traditional multiple sclerosis medications. All participants received stem cell therapy from different medical centers throughout Italy.
A more stringent clinical trial will reveal additional details about the efficacy of stem cell therapy for MS treatments. Additional research will help medical professionals identify who is best suited for stem cell therapy and when they should undergo this intervention. This research aims to determine if stem cells will stimulate the patient’s natural immune system so that it can begin functioning normally again. This could result is a breakthrough against MS!
How Stem Cells May Be Able to Help MS Sufferers
Human MSCs (mesenchymal stem cells) are adult stem cells found in various body tissues. This includes the bone marrow, adipose tissue, and umbilical cord tissues. MSCs have the potential to help patients suffering from a wide array of medical conditions, including MS.
Since stem cells serve as the building blocks for the immune system, this intervention could potentially stimulate natural healing. By injecting the patient with MSCs derived from bone marrow aspirate or adipose tissue, clinicians may be able to reduce the severity of symptoms. Stem cell therapy might be able to slow the progression of the condition, but these benefits are still undergoing research.
Patients suffering from MS and searching for a breakthrough against MS and an alternative treatment option may want to consider stem cell therapy, as the potential benefits greatly outweigh any risks associated with the treatment. If you would like to learn more, contact us today to speak with a care coordinator.
by admin | Oct 13, 2021 | Multiple Sclerosis, Health Awareness, Stem Cell Therapy
Several million people across the globe are living with the condition known as MS or multiple sclerosis. The majority of them were diagnosed with this condition between 20-40 years of age.
Due to the complexity of the condition, diagnosing MS requires a multi-stage testing process. Once a positive diagnosis has been obtained, patients have several treatment options available to them, which we’ll outline below.
The Diagnosis Process
To diagnose multiple sclerosis, doctors rely on a variety of tests that are designed to rule out other medical conditions. This is necessary because there are no specific diagnostic procedures for detecting MS. The diagnosis process may include:
Blood Tests: During initial testing, blood samples are used to rule out common conditions that present similar symptoms to MS. These blood tests also check for unique biomarkers that are associated with MS.
Spinal Tap: Depending on the results of the blood tests, the physician may schedule a spinal tap next. This test involves puncturing the lumbar spine in order to remove a small amount of cerebrospinal fluid. The fluid is then subjected to laboratory analysis and checked for abnormal antibodies linked to MS.
MRI: An MRI or magnetic resonance imaging test is used to identify lesions on the spinal cord and brain. These lesions are a common sign of MS. Oftentimes, patients receive an IV injection of a “contrast material.” This substance helps to highlight legions during the MRI scan.
Evoked Potential Tests: An evoked potential test documents electrical signals that are created by your nervous system. It can use electrical stimuli or verbal stimuli in order to prompt your nervous system to create impulses. The goal of this test is to determine how fast information is traveling down nerve pathways.
MS Treatment Options
While MS has no cure, there are several viable treatment options available. These treatments can enhance the quality of life of MS sufferers and mitigate their symptoms. MS treatments include:
Corticosteroids: Corticosteroids are used to reduce nerve inflammation. They can be administered orally or through an IV. However, corticosteroids do present a risk for several side effects, such as insomnia and increased blood sugar.
Plasma Exchange: Plasma is the liquid component of blood. During this treatment, the plasma is removed and separated from the patient’s blood cells. The cells are combined with albumin (protein solution) and put back into the patient’s body.
Stem Cell Therapy: Stem cell therapy is an alternative treatment option for patients with MS. It is being used to potentially help patients suffering from symptoms of neurodegenerative conditions. Stem cells stimulate the body’s natural healing capabilities and have the potential to help manage MS symptoms. If you or a loved one suffers from MS, stem cell therapy may be an option to explore as an alternative treatment.
by Stemedix | Aug 9, 2021 | Multiple Sclerosis, Stem Cell Therapy
In the United States, nearly one million people suffer from multiple sclerosis (MS). That is nearly one in 330 people nationwide. While the condition is not exceedingly common, it also cannot be classified as rare. The current number of people who have MS has doubled which is why more researchers have been delving into ways to treat the condition. For MS, the mean age of patients at the time of diagnosis is 34 years. The vast majority of patients are diagnosed between the ages of 20 and 50. However, MS has also been known to affect children and teenagers. In this article, we are going to talk about the stem cell transplant benefits for patients with MS.
The Slowing of Progression
Much of the research and medical development for MS have been focused on slowing the progression of the disease. There are currently several medications on the market that are geared toward doing just that. There has also been stem cell research done that has shown positive results.
While many drugs have succeeded in slowing the progression rate of MS, one important downside is the cost. Long-term use of these medications can affect a patient’s budget. If remission is gained, however, the patient can discontinue those drugs indefinitely.
One experiment involved patients from four countries, including the United States. All of the patients were given chemotherapy. Following this treatment, half were given drugs and the other half were administered stem cell therapy.
All patients that received the stem cell injections were clear from recurring symptoms after a year. Only six out of 52 had recurring symptoms after three years. The results of this experiment were released just a few years ago and have garnered the attention of researchers, as well as the desire for more trials.
Older Research
Stem cell therapy for the treatment of MS has been around for longer than most people realize. It began in the 1990s with hematopoietic stem cells, or HSC transplants, for patients that were not responding well to the conventional medications given at the time.
The method used for some of these trials was immunoablation. This is the process of partially destroying a faulty immune system and then replacing it with newer, healthier cells. Researchers have used it in further studies based on its early encouraging results. With this in mind, there may be hope on the horizon for the use of stem cells to achieve remission. If you are interested in scheduling a consultation contact a care coordinator today!
by admin | Jul 30, 2021 | Stem Cell Research, Multiple Sclerosis, Stem Cell Therapy
Typically understood to support hematopoiesis and to produce the cells of the mesodermal lineage, mesenchymal stem cells (MSCs) found in bone marrow, fat, and other tissues of the body, have recently been found to contain additional properties that include immunomodulator and neurotrophic effects.
Considering earlier studies that have demonstrated favorable effects of MSC treatments in a variety of conditions – including stroke, multiple sclerosis, multi-system atrophy, and amyotrophic lateral sclerosis, Petrou et al. performed this double-blind study as a way to evaluate the best way of administration and the safety and clinical efficacy of MSC transplantation – specifically in patients with active and progressive multiple sclerosis.
The response of the 48 patients with progressive multiple sclerosis and with displaying evidence of either clinical worsening or activity during the previous year in this study were evaluated after being treated intrathecally (IT) or intravenously (IV) with autologous MSCs or with sham injections. Having identified a critical and unmet need for treatment, the goal of Petrou et al.’s study was to examine the therapeutic efficacy of MSC transplantation in this specific population.
Over the course of this controlled clinical trial, participants were randomly assigned to three treatment groups and treated (either intrathecally or intravenously) with autologous MSCs or with sham injections. At the 6-month mark, the authors of this study retreated half of the patients in both the MSC-IT and MSC-IV groups with MSCs, while the remaining participants were treated with sham injections. The same process occurred with patients initially treated with sham injections; meaning that at the 6-month mark, half were either treated with MSC-IT or MSC-IV.
Prior to the start of this study, Petrou et al. established a number of primary and secondary endpoints. Predetermined primary endpoints of this study included: the safety of the MSC-IV and MSC-IT treatments and the difference among the three groups in relation to performance on the Expanded Disability Status Scale (EDSS) at 6- and 12-month intervals. Predetermined secondary endpoints included the difference between the sham-treated and MSC-IT or MSC-IV treated group in the number of relapses and the relapse rate, the number of MRI gadolinium-enhancing lesions, the annualized rate of change in the T2 lesion load on MRI, percent brain volume change, performance on a series of physical and cognitive functions, and the retinal nerve fiber layer thickness.
At the conclusion of this 14-month trial, the authors reported that the study demonstrated positive results in all predetermined primary endpoints. More specifically, throughout the course of this study, the authors discovered that significantly fewer patients experienced treatment failure in the MSC0IT and MSC-IV groups compared with those in the sham-treated group. Additionally, over the course of the following year, nearly 59% and 41% of patients treated with MSC-IT and MSC-IV exhibited no evidence of multiple sclerosis activity; this is compared with less than 10% of patients in the sham-treated group.
Significant improvements of those receiving MSC-IT treatment (compared to sham treatment) were also observed in the following: ambulation index, the sum of functional scores, 25-foot timed walk test, 9-hole peg tests, PASAT and OWAT/KAVE cognitive tests, and newer biomarkers, including retinal nerve fiber layer and motor network. The authors also report beneficial, but less significant effects were observed in the MSC-IV groups.
Although the authors report a number of limitations associated with this study, including a small number of patients in each group, the short duration of the study, and the crossover design of the study (which could have resulted in a “carry-over” effect from the first cycle of treatment), they also conclude that the clinically significant findings observed in patients with progressive multiple sclerosis who were previously unresponsive to traditional or conventional therapies provide clear evidence of short-term efficacy and possible indications of neuroprotection induced by administration of autologous MSCs in patients with progressive multiple sclerosis.
In addition, the authors found that intrathecal administration of MSCs appears more beneficial than intravenous, as well as the potential benefits provided by receiving repeated injections of MSCs.
As such, Petrou et al. conclude by calling for a larger phase III study to confirm these findings and as a way to further evaluate the therapeutic potential of autologous MSCs in neuroinflammatory and neurodegenerative diseases, including active progressive multiple sclerosis.
Source: (2020, December 1). Beneficial effects of autologous mesenchymal stem cell … – PubMed. from https://pubmed.ncbi.nlm.nih.gov/33253391/
St. Petersburg, Florida
